Oral Proteins And Peptides Market Report 2026
Download Free Sample Buy Now
Oral Proteins And Peptides Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Oral Proteins And Peptides Market Report 2026

Global Outlook – By Drug Type (Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide), By Biological Target (Guanylate Cyclase-C (GC-C), Insulin Receptor, Other Biological Targets), By Mechanism Of Action (Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action), By Application (Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Oral Proteins And Peptides Market Overview

• Oral Proteins And Peptides market size has reached to $1.56 billion in 2025

• Expected to grow to $4.26 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%

• Growth Driver: Growing Biopharmaceutical Industry

• Market Trend: Technological Advancements in the Oral Proteins and Peptides Market to Enhance Bioavailability and Patient Compliance

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oral Proteins And Peptides Market?

Oral Proteins and Peptides refer to therapeutic proteins and peptides administered orally, typically in pills, capsules, or other ingestible formats. These biologically active molecules are designed to treat various medical conditions by leveraging their specific actions within the body.

The main drug types of oral proteins and peptides are linaclotide, calcitonin, insulin, plecanatide, and octreotide. The biological targets are guanylate cyclase-c (gc-c), insulin receptor, oxalate, and others, and the different mechanisms of action are receptor stimulation, substrate degradation, and others. It is used for various applications such as gastrointestinal disorders, bone disease, neurological disorders, diabetes, metabolic disorders, hormonal disorders, and cancer.

Oral Proteins And Peptides Market Global Report 2026 Market Report bar graph

What Is The Oral Proteins And Peptides Market Size and Share 2026?

The oral proteins and peptides market size has grown exponentially in recent years. It will grow from $1.56 billion in 2025 to $1.91 billion in 2026 at a compound annual growth rate (CAGR) of 22.5%. The growth in the historic period can be attributed to limited oral bioavailability of proteins and peptides, reliance on injectable formulations, growing prevalence of diabetes and gastrointestinal disorders, increasing research in peptide therapeutics, regulatory approvals for early oral peptide drugs.

What Is The Oral Proteins And Peptides Market Growth Forecast?

The oral proteins and peptides market size is expected to see exponential growth in the next few years. It will grow to $4.26 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to development of novel delivery technologies for oral proteins, expansion of chronic disease management programs, rising adoption of personalized and combination therapies, increasing healthcare expenditure on metabolic and hormonal disorders, integration of digital adherence and monitoring tools. Major trends in the forecast period include rising adoption of oral insulin and other therapeutic peptides, growth in personalized medicine and targeted oral protein therapies, increasing focus on gastrointestinal disorder treatments, expansion of oral protein formulations for diabetes and metabolic disorders, advancement in long-acting and combination oral protein products.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Oral Proteins And Peptides Market Segmentation

1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide

2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Other Biological Targets

3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action

4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer

Subsegments:

1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)

2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment

3) By Insulin: Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations

4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)

5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors

What Is The Driver Of The Oral Proteins And Peptides Market?

The growing biopharmaceutical industry is expected to propel the growth of the oral proteins and peptides market going forward. The biopharmaceutical industry is a sector within the broader pharmaceutical industry that focuses on developing, producing, and commercializing drugs derived from biological sources. The growth of the biopharmaceutical industry is due to advancements in biotechnology, growing demand for personalized medicine, increasing prevalence of chronic diseases, and rising investment in research and development. Oral proteins and peptides in biopharmaceuticals offer potential for non-invasive delivery of therapeutics, enhancing patient compliance and reducing the need for injections. They can target specific diseases with improved stability and absorption in the digestive system. For instance, in October 2025, according to the Bioscience and Health Technology Sector, a UK-based government statistics, in 2023/2024, there were 6,170 businesses operating in the UK life sciences industry across 7,320 companies. These businesses employed 359,600 people and generated £146.9 ($169.69) billion in turnover. Therefore, the growing biopharmaceutical industry is driving the growth of the oral proteins and peptides industry.

Key Players In The Global Oral Proteins And Peptides Market

Major companies operating in the oral proteins and peptides market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.

Global Oral Proteins And Peptides Market Trends and Insights

Major companies operating in the oral proteins and peptides market are focusing on developing innovative formulation technologies to enhance peptide stability, permeability, and bioavailability in oral dosage forms. These advancements aim to overcome traditional challenges such as enzymatic degradation and poor absorption in the gastrointestinal tract. For instance, in August 2025, BioMed X, a Germany-based biomedical research institute, launched a new collaboration with Novo Nordisk, a Denmark-based pharmaceutical company, to accelerate the development of next-generation oral peptide delivery technologies. The partnership will explore novel molecular strategies and delivery mechanisms to enable safe, effective, and patient-friendly oral peptide therapeutics. By integrating BioMed X’s early-stage research capabilities with Novo Nordisk’s expertise in peptide-based medicines, the collaboration aims to advance breakthrough oral drug delivery solutions and expand the therapeutic potential of peptide medicines across metabolic and chronic diseases.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Oral Proteins And Peptides Market?

In April 2023, Chiesi Farmaceutici S.p.a., an Italy-based pharmaceutical company, acquired Amryt Pharma Plc for an undisclosed amount. This acquisition enables Chiesi to harness Amryt's distinctive products and promising pipeline, reinforcing its dedication to rare diseases and enhancing its biopharmaceutical capabilities. Amryt Pharma Plc is a UK-based provider of oral proteins and peptides.

Regional Insights

North America was the largest region in the oral proteins and peptides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oral Proteins And Peptides Market?

The oral proteins and peptides market consists of sales of protein supplements, peptide-based drugs, and therapeutic formulations designed for oral administration. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oral Proteins And Peptides Market Report 2026?

The oral proteins and peptides market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oral proteins and peptides industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Oral Proteins And Peptides Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.91 billion
Revenue Forecast In 2035 $4.26 billion
Growth Rate CAGR of 22.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Type, Biological Target, Mechanism Of Action, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Pal
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Oral Proteins And Peptides Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Oral Proteins And Peptides Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Oral Proteins And Peptides Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Oral Proteins And Peptides Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Oral Insulin And Other Therapeutic Peptides

4.2.2 Growth In Personalized Medicine And Targeted Oral Protein Therapies

4.2.3 Increasing Focus On Gastrointestinal Disorder Treatments

4.2.4 Expansion Of Oral Protein Formulations For Diabetes And Metabolic Disorders

4.2.5 Advancement In Long-Acting And Combination Oral Protein Products

5. Oral Proteins And Peptides Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Pharmacies

5.4 Diabetes Care Centers

5.5 Research & Academic Institutions

6. Oral Proteins And Peptides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oral Proteins And Peptides Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Oral Proteins And Peptides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Oral Proteins And Peptides Market Size, Comparisons And Growth Rate Analysis

7.3. Global Oral Proteins And Peptides Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Oral Proteins And Peptides Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oral Proteins And Peptides Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oral Proteins And Peptides Market Segmentation

9.1. Global Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide

9.2. Global Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Guanylate Cyclase-C (GC-C), Insulin Receptor, Other Biological Targets

9.3. Global Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action

9.4. Global Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer

9.5. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)

9.6. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Calcitonin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment

9.7. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations

9.8. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Plecanatide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)

9.9. Global Oral Proteins And Peptides Market, Sub-Segmentation Of Octreotide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors

10. Oral Proteins And Peptides Market Regional And Country Analysis

10.1. Global Oral Proteins And Peptides Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Oral Proteins And Peptides Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oral Proteins And Peptides Market

11.1. Asia-Pacific Oral Proteins And Peptides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oral Proteins And Peptides Market

12.1. China Oral Proteins And Peptides Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oral Proteins And Peptides Market

13.1. India Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oral Proteins And Peptides Market

14.1. Japan Oral Proteins And Peptides Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oral Proteins And Peptides Market

15.1. Australia Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oral Proteins And Peptides Market

16.1. Indonesia Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oral Proteins And Peptides Market

17.1. South Korea Oral Proteins And Peptides Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oral Proteins And Peptides Market

18.1. Taiwan Oral Proteins And Peptides Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oral Proteins And Peptides Market

19.1. South East Asia Oral Proteins And Peptides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oral Proteins And Peptides Market

20.1. Western Europe Oral Proteins And Peptides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oral Proteins And Peptides Market

21.1. UK Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oral Proteins And Peptides Market

22.1. Germany Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oral Proteins And Peptides Market

23.1. France Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oral Proteins And Peptides Market

24.1. Italy Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oral Proteins And Peptides Market

25.1. Spain Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oral Proteins And Peptides Market

26.1. Eastern Europe Oral Proteins And Peptides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oral Proteins And Peptides Market

27.1. Russia Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oral Proteins And Peptides Market

28.1. North America Oral Proteins And Peptides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oral Proteins And Peptides Market

29.1. USA Oral Proteins And Peptides Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oral Proteins And Peptides Market

30.1. Canada Oral Proteins And Peptides Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oral Proteins And Peptides Market

31.1. South America Oral Proteins And Peptides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oral Proteins And Peptides Market

32.1. Brazil Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oral Proteins And Peptides Market

33.1. Middle East Oral Proteins And Peptides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oral Proteins And Peptides Market

34.1. Africa Oral Proteins And Peptides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Oral Proteins And Peptides Market, Segmentation By Drug Type, Segmentation By Biological Target, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oral Proteins And Peptides Market Regulatory and Investment Landscape

36. Oral Proteins And Peptides Market Competitive Landscape And Company Profiles

36.1. Oral Proteins And Peptides Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Oral Proteins And Peptides Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Oral Proteins And Peptides Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

37. Oral Proteins And Peptides Market Other Major And Innovative Companies

Eli Lilly and Company, Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.

38. Global Oral Proteins And Peptides Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oral Proteins And Peptides Market

40. Oral Proteins And Peptides Market High Potential Countries, Segments and Strategies

40.1 Oral Proteins And Peptides Market In 2030 - Countries Offering Most New Opportunities

40.2 Oral Proteins And Peptides Market In 2030 - Segments Offering Most New Opportunities

40.3 Oral Proteins And Peptides Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Oral Proteins And Peptides Market, Overview Of Key Products - Product Examples
  • Table 2: Global Oral Proteins And Peptides Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Oral Proteins And Peptides Market, Supply Chain Analysis
  • Table 4: Global Oral Proteins And Peptides Market, Major Raw Material Providers
  • Table 5: Global Oral Proteins And Peptides Market, Major Resource Providers
  • Table 6: Global Oral Proteins And Peptides Market, Major Manufacturers (Suppliers)
  • Table 7: Global Oral Proteins And Peptides Market, Major Distributors And Channel Partners
  • Table 8: Global Oral Proteins And Peptides Market, Key Technologies & Future Trends
  • Table 9: Global Oral Proteins And Peptides Market, Major Trends
  • Table 10: Global Oral Proteins And Peptides Market, Major End Users
  • Table 11: Global Oral Proteins And Peptides Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Oral Proteins And Peptides Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Oral Proteins And Peptides Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Oral Proteins And Peptides Market - TAM, US$ Billion, 2025
  • Table 15: Global Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Calcitonin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Plecanatide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Octreotide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Oral Proteins And Peptides Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Oral Proteins And Peptides Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Oral Proteins And Peptides Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Oral Proteins And Peptides Market - Company Scoring Matrix
  • Table 100: Pfizer Inc. Financial Performance
  • Table 101: Merck & Co. Inc. Financial Performance
  • Table 102: AbbVie Inc. Financial Performance
  • Table 103: Sanofi S.A. Financial Performance
  • Table 104: AstraZeneca PLC Financial Performance
  • Table 105: Global Oral Proteins And Peptides Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Oral Proteins And Peptides Market, Competitive Dashboard
  • Table 107: Global Oral Proteins And Peptides Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Oral Proteins And Peptides Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Table 109: Global, Oral Proteins And Peptides Market Size Gain ($ Billion), Segmentation By Biological Target, 2025 – 2030
  • Table 110: Global, Oral Proteins And Peptides Market Size Gain ($ Billion), Segmentation By Mechanism Of Action, 2025 – 2030

List Of Figures

    Figure 1: Global Oral Proteins And Peptides Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Oral Proteins And Peptides Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Oral Proteins And Peptides Market, Supply Chain Analysis
  • Figure 4: Global Oral Proteins And Peptides Market, Major Raw Material Providers
  • Figure 5: Global Oral Proteins And Peptides Market, Major Resource Providers
  • Figure 6: Global Oral Proteins And Peptides Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Oral Proteins And Peptides Market, Major Distributors And Channel Partners
  • Figure 8: Global Oral Proteins And Peptides Market, Key Technologies & Future Trends
  • Figure 9: Global Oral Proteins And Peptides Market, Major Trends
  • Figure 10: Global Oral Proteins And Peptides Market, Major End Users
  • Figure 11: Global Oral Proteins And Peptides Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Oral Proteins And Peptides Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Oral Proteins And Peptides Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Oral Proteins And Peptides Market - TAM, US$ Billion, 2025
  • Figure 15: Global Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Calcitonin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Plecanatide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Oral Proteins And Peptides Market, Sub-Segmentation Of Octreotide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Oral Proteins And Peptides Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Oral Proteins And Peptides Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Oral Proteins And Peptides Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Oral Proteins And Peptides Market - Company Scoring Matrix
  • Figure 100: Pfizer Inc. Financial Performance
  • Figure 101: Merck & Co. Inc. Financial Performance
  • Figure 102: AbbVie Inc. Financial Performance
  • Figure 103: Sanofi S.A. Financial Performance
  • Figure 104: AstraZeneca PLC Financial Performance
  • Figure 105: Global Oral Proteins And Peptides Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Oral Proteins And Peptides Market, Competitive Dashboard
  • Figure 107: Global Oral Proteins And Peptides Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Oral Proteins And Peptides Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Figure 109: Global, Oral Proteins And Peptides Market Size Gain ($ Billion), Segmentation By Biological Target, 2025 – 2030
  • Figure 110: Global, Oral Proteins And Peptides Market Size Gain ($ Billion), Segmentation By Mechanism Of Action, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Oral Biologics & Biosimilar Drugs Market Report 2026 - Global Outlook – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, ...

Oral Contraceptive Pills Market Report 2026 - Global Outlook – By Type (Combination, Progestin Only, Other Types), By Category (Generic, Branded), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Onl...

Oral Thin Films Market Report 2026 - Global Outlook – By Type (Sublingual Film, Fast Dissolving Dental/Buccal Film), By Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Other Disease Ind...

Oral Biologics & Biosimilars Market Report 2026 - Global Outlook – By Therapy (Lymphocyte Modulators, Immunostimulants, GPCR Modulators, Other Therapies), By Disease (Diabetes, Arthritis and Crohn’s Disease, Cancer, Infe...

Oral Care Market Report 2026 - Global Outlook – By Product Type (Toothpaste, Mouth Wash And Rinse, Teeth Whitening, Dental Floss, Tooth Brush, Orthodontic Wax), By Distribution Channel (Store-Based, Non-Store-Based), By ...

Intraoral Cameras Market Report 2026 - Global Outlook – By Type (USB Camera, Fiber Optic Camera, Wireless Cameras, Other Types), By Application (Implantology, Endodontic, Oral And Maxillofacial Surgery, Orthodontics, Oth...

Behavioral and Mental Health Software Market Report 2026 - Global Outlook – By Component (Support Services, Software), By Type (Clinical Software, Financial Software, Administrative Software, Other Types), By Delivery Mo...

Behavioral Biometrics Market Report 2026 - Global Outlook – By Components (Software, Services), By Type (Keystroke Dynamics, Gait Analysis, Signature Analysis, Voice Recognition), By Deployment Model (Cloud, On-Premises)...

Frequently Asked Questions

The Oral Proteins And Peptides market was valued at $1.56 billion in 2025, increased to $1.91 billion in 2026, and is projected to reach $4.26 billion by 2030.

The global Oral Proteins And Peptides market is expected to grow at a CAGR of 22.2% from 2026 to 2035 to reach $4.26 billion by 2035.

Some Key Players in the Oral Proteins And Peptides market Include, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd. .

Major trend in this market includes: Technological Advancements in the Oral Proteins and Peptides Market to Enhance Bioavailability and Patient Compliance. For further insights on this market. request a sample here

North America was the largest region in the oral proteins and peptides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us